Vijaya Diagnostic Centre Limited (NSE: VIJAYA)

Market Cap	125.16B
Revenue (ttm)	6.27B
Net Income (ttm)	1.33B
Shares Out	102.62M
EPS (ttm)	12.91
PE Ratio	94.46
Forward PE	70.23
Dividend	1.00 (0.08%)
Ex-Dividend Date	Aug 30, 2024

Volume	1,812,619
Open	1,142.00
Previous Close	1,147.90
Day's Range	1,128.55 - 1,249.95
52-Week Range	584.40 - 1,249.95
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 an...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 2,053
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIJAYA

Financial Performance

In 2023, Vijaya Diagnostic Centre's revenue was 5.48 billion, an increase of 19.29% compared to the previous year's 4.59 billion. Earnings were 1.19 billion, an increase of 40.40%.